Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe brain and balance to unlock Parkinson's freezing mystery

NCT ID NCT06506058

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study investigates why people with Parkinson's disease sometimes freeze while walking or turning. Researchers will use gentle electrical stimulation to the balance system and brain wave recordings to understand the signals involved. The goal is to find biological markers that could lead to better treatments, like brain stimulation, to prevent freezing and reduce fall risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electrical vestibular stimulation (EVS) and electroencephalography (EEG) recordings
What this could lead to
If successful, this research could identify brain and balance signals linked to freezing episodes, guiding the development of new treatments like brain stimulation to reduce falls.
What could go wrong
This is an early-stage observational study, not a treatment trial. It aims to understand the problem, not test a cure, so direct patient benefits are not expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants with Parkinson's disease (with and without Freezing of Gait) * Diagnosis of idiopathic PD. * Age 40-80 years. * Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters. Healthy Older Adults (Control participants) * Age 40-80 years (this group will be age- and sex-matched to the PD and FOG group). * Able to ambulate independently without the use of an assistive device (cane or walker). * Normal capacity to perform complex activities of daily living independently based on informant or physician report. Healthy Young Adults * Age 21-44 years (this group will be sex-matched to the PD and FOG group) * Able to ambulate independently without the use of an assistive device (cane or walker) Exclusion Criteria: Exclusion Criteria (for all participants): * Any musculoskeletal disorder that affects the ability to stand or walk. * History of musculoskeletal disorders that significantly affect movement of lower limbs. * Uncorrected visual impairment that may affect participation or performance in the study. * History of visual and/or vestibular conditions that may affect participation or performance in the study. * Meet criteria for dementia with Lewy bodies, Multiple Systems Atrophy, Alzheimer's disease, dementia diagnosis, or other neurodegenerative disorder other than Parkinson's disease. * History of seizures, epilepsy, stroke, multiple sclerosis, or traumatic brain injury or other significant neurological disorders that may affect participation or performance in the study. * History of muscular conditions of the neck and back, including whiplash. * History of surgery on blood vessels, brain, or heart. * Unexplained, recurring headaches or concussion within the last six months. * Moderate to severe hearing impairment. * Subjects who are pregnant * Reduced capacity to consent. This will be assessed using a 2-stage process. Initially, participants will be tested using the University of California, San Diego, Brief Assessment of Capacity to Consent (UBACC). If the results of the UBACC are inconclusive the individual will be further tested using the MacArthur Competency Assessment Tool for Clinical Research (McCAT-CR). Additional exclusion criteria for EVS Experiments (Experiments 1 and 2): * History of motion sickness (as EVS can exacerbate motion sickness). * Intense physical exercise or consumption of alcohol in the 24 hours prior to any experiment that will include EVS testing. * Recent history of migraine headaches. * Intracranial metallic or magnetic devices. * Pacemaker or any implanted device. * Implanted deep brain stimulator or other neurosurgeries to treat PD. * Use of medications that can cause dizziness. Additional exclusion criteria for Control Participants: * Presence of parkinsonism or cognitive impairment (including dementia or mild cognitive impairment). * Active central nervous system, systemic, psychiatric conditions or use of psychoactive medication that would adversely affect cognitive, neuropsychiatric, motor, or autonomic functioning.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Minnesota, Movement Disorders Lab

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.